baber/WOPTO huggingface dataset:
Patent SI-2971421-T1 (SI)
Title: Decelerated hinge for furniture
Inventor: SALICE LUCIANO
IPC: E05F5/00
Filed: 2014-09-09
Abstract: A hinge (10) for moounting a door on a piece of furniture or the like comprises a hinge arm (11) securable to a fixed part (12) of the piece of furniture, a box (14) securable to a door of the piece of furniture and connected to the hinge arm (11) by an articulation system (15) comprising a plurality of swinging connecting levers and spring means (27) acting in the closing direction of the hinge (10); the hinge (10) further comprises a decelerating device (29) comprising a housing body (30), supported and configured in such a way so as to be disposed at one of the front or side wall (11′, 11″) of the hinge arm (11), and a linearly movable actuating member (31) actuatable by one (18) of the swinging connecting levers of the articulation system (15) of the hinge.
Patent SI-3033944-T1 (SI)
Title: Calcium carbonate for plant protection
Inventor: STURM CHRISTOPH
IPC: A01P7/00
Filed: 2014-12-16
Abstract: The present invention relates to the use of calcium carbonate as plant protection product for topical, pre-harvest application, wherein the plant protection product controls a pest during plant growth.
Patent DE-3280439-T2 (DE)
Inventor: POLLARD RAYMOND JAMES
IPC: F28D9/00
Filed: 1982-08-26
Granted: 1993-11-04
Abstract: This invention relates to fluid flow apparatus such as a heat exchanger. The heat exchanger includes inlet means, outlet means and a core element. The core element has a plurality of flow passages for a process fluid and a multiplicity of flow passages for a working fluid wherein each respective process fluid passage is located adjacent to a corresponding working fluid passage. There is also provided means for selectively controlling the direction of process fluid and/or working fluid on passage through the core element.It is also within the scope of the invention that the heat exchanger may be utilized to treat a plurality of different fluids or working fluids. Suitably the fluid flow apparatus includes an inlet component, an outlet component and the core element and it is the specific juxta position of these members that provides the means for selectively controlling direction of process fluid and/or working fluid through the core element
Patent DE-3586793-T2 (DE)
Inventor: HESCH ROLF-DIETER PROF DR
IPC: A61K38/22
Filed: 1985-08-30
Granted: 1993-03-18
Abstract: Fully synthetic alpha-human atrial natriuretic peptide (alpha-hANaP) in a highly purified injectable or infusible form is useful for treating cardiac insufficiency, more specifically with oedematosis and sodium retention, oliguric renal failure, blood pressure disregulation and ascites in chronic liver diseases, vasopressin disregulation, posterior pituitary malfunction, and the psychotropic effects induced thereby.
Patent DE-3751305-T2 (DE)
Inventor: WRIGHT WORTLEY
IPC: H04N7/16
Filed: 1987-05-29
Granted: 1995-09-14
Abstract: A signal matching signal substitution system includes a tuner (24A, 24B) for selectively receiving signals in respective television channels with an input gain control (42) for controlling the signal output level of the tuner (24A, 24B). The system substitutes television signals in a substitute channel in lieu of normal signals in a normal channel selected by a viewer. The system has a component (228) for determining the input signal level of currently received signals in a currently received channel and generating a current amplitude signal. A set point generator (56, 232A) is responsive to the current amplitude signal corresponding to the normal channel most currently received for providing a set point for the output signal level. A gain contol signal generator (63, 86) is responsive to the set point and the signal output level for generating a gain control signal maintaining the output level at the set point. The set point may be set at a predetermined fixed level when the current amplitude signal corresponding to the most current normal channel is relatively high and is set at progressively lower levels when the current amplitude signal corresponding to the most current normal channel is below a transition level. The set point at the progressively lower levels is noise limited to provide substantially equal signal to noise ratios in the signal output of the tunner (24A, 24B) in both the normal and the substitute channels upon signal substitution. The set point is gain limited to the maximum signal output achievable by the gain control (42) for the normal channel.
Patent DE-3780079-T2 (DE)
Inventor: SPIJKER RUUD
IPC: C01B25/238
Filed: 1987-04-23
Granted: 1993-02-18
Abstract: Virtually cadmium-free calcium sulphate is produced in the preparation of a liquid medium containing phosphoric acid, which comprises digestion with a mineral acid of cadmium-containing phosphate rock and separation from the liquid medium containing phosphoric acid of at least a portion of the calcium in the phosphate rock after precipitation by means of a solution containing sulphate ions in the form of calcium sulphate, in which process halogen ions are present in an amount of 50-20.000 ppm during precipitation of the calcium sulphate to be separated.
Patent DE-3854120-T2 (DE)
Inventor: EVANS RONALD MARK
IPC: C12Q1/68
Filed: 1988-12-02
Granted: 1996-01-11
Abstract: A novel retinoic acid receptor is disclosed. The novel receptor is encoded for by cDNA carried on plasmid phRAR1, which has been deposited with the American Type Culture Collection for patent purposes. Chimeric receptor proteins are also disclosed. The chimera are constructed by exchanging functional domains between the glucocorticoid, the mineralocorticoid, the estrogen-related, the thyroid and the retinoic acid receptors. In addition, a novel method for identifying functional ligands for receptor proteins is disclosed. The method, which takes advantage of the modular structure of the hormone receptors and the idea that the functional domains may be interchangeable, replaces the DNA-binding domain of a putative novel receptor with the DNA-binding domain of a known receptor such as the glucocorticoid receptor. The resulting chimeric construction, when expressed in cells, produces a hybrid receptor whose activation of a ligand-(e.g., glucocorticoid) inducible promoter is dependent on the presence of the new ligand. The novel method is illustrated in part by showing that the ligand for the new receptor protein is the retinoid, retinoic acid. <IMAGE>
Patent DE-3854466-T2 (DE)
Inventor: LEYLAND JOHN DEREK
IPC: H01J29/48
Filed: 1988-12-02
Granted: 1996-05-02
Abstract: The gun comprises a cathode (C), a control grid (G), a first anode (A1) a second anode (A2) and a third anode (A3). Preferably a beam width limiting aperture (BL) is provided in the first anode (A1). In one example the current modulating voltage applied to the grid is 0 to -50V, the voltage applied to the first anode is +5kV, the focus voltage applied to the second anode is +500V, and the EHT voltage applied to the third anode is +25kV. A main focussing lens is formed by the second and third anodes, but the spacing of the first and third anodes is small so that the focussing effect is also substantially dependent on the voltage of the first anode. The field strength between the grid and first anode is high, which combined with the high A1 voltage produces a small crossover.
Patent DE-3873423-T2 (DE)
Inventor: GOLDBERG DANIEL
IPC: C08K3/36
Filed: 1988-02-23
Granted: 1993-03-11
Abstract: A cavitation resistant polymer and coating are provided by curing a composition containing from about 24 to 48 wt.% of a liquid epoxy resin, from about 24 to 48 wt.% of a blocked isocyanate prepolymer, from about 4.2 to 12 wt.% of a rheological additive at least 65% of which is an amorphous silica flatting agent, from about 10 to 14 wt.% of a curing agent, from about 1 to 4 wt.% of a plasticizer, and from about 0.1 to 0.6 wt.% of a silane. The composition can contain pigments, fillers and other auxillary agents.
Patent DE-3878157-T2 (DE)
Inventor: YEDGAR SAUL
IPC: A61K47/00
Filed: 1988-10-24
Granted: 1993-05-27
Abstract: Inhibitors of phospholipase A2 activity at the cell-surface membrane whose molecular structure comprises a cell-permeable PLA2-inhibitor moiety covalently bonded directly or indirectly to a physiologically acceptable carrier moiety which is effective to inhibit cell internalisation of the cell-permeable PLA2-inhibitor moiety, with the proviso that phosphatidylserine is not bonded indirectly via divalent dodecanedioyl to dextrane hydrazide.
Patent DE-3881408-T2 (DE)
Inventor: YOSHIOKA TAKAO
IPC: A61K31/38
Filed: 1988-02-04
Granted: 1994-01-20
Abstract: Thiazolidinone derivatives of formula (I): <CHEM> in which R<1>, R<2>, R<3>, R<4> and R<5> are various atoms or organic groups, Ar is an aromatic group and n, is an integer have valuable pharmacological activities including the ability to reduce blood glucose levels and blood lipid levels.
Patent DE-3885372-T2 (DE)
Inventor: LOHKAMP DWIGHT THEODORE
IPC: B29C48/345
Filed: 1988-07-19
Granted: 1994-03-10
Abstract: High melt flow rate polymers are pelletized with greater uniformity and less malformed pellets from underwater extrusion processes by die orifices having a narrow preland sufficient to evenly distribute the polymer followed by a wide final hole that forms a polymer strand sufficient to avoid deformation by water currents during pelletization.
Patent DE-3886180-T2 (DE)
Inventor: GLEASON PATRICK D
IPC: C09J103/00
Filed: 1988-10-28
Granted: 1994-07-14
Abstract: Aqueous starch-based adhesives for use in a variety of applications can be made alkali sensitive or can have enhanced cleanability under aqueous conditions.
Patent DE-3887411-T2 (DE)
Inventor: YAGI KAZUO
IPC: D01F6/30
Filed: 1988-09-05
Granted: 1994-05-11
Abstract: Disclosed is a molecularly oriented molded body of an ultra-high-molecular-weight ethylene/polyene copolymer having an intrinsic viscosity ( eta ) of at least 5 d l /g and such a content of a polyene that the number of molecules of the polyene is 0.01 to 15 on the average per 1000 carbon atoms, wherein the molded body shows at least two crystal fusion endothermic peaks when the measurement is conducted in the restraint state by using a differential scanning calorimeter, the molded body has at least one crystal fusion endothermic peak (Tp) at a temperature higher by at least 20 DEG C than the inherent crystal fusion temperature (Tm) of the ultra-high-molecular-weight ethylene/polyene copolymer determined as the main fusion endothermic peak at the time of the second elevation of the temperature, and the quantity of heat based on said crystal fusion endothermic peak (Tp) is at least 15% based on the total fusion heat quantity.
Patent TR-199802618-T2 (TR)
Inventor: BEWICK-SONNTAG CHRISTOPHER PHI
IPC: A61F13/15
Filed: 1997-06-17
Abstract: Bu bulus, koruma seviyesi performansi muhafaza edilirken, özellikle hava/gaz geçirebilir arka-tabakalarin kullanilmasiyla, gelistirilmis rahatliga sahip olan özelde hijyenik kadin baglari olan emici esyalara iliskindir. Bu sonuç, emici esya için belirlenen gerekleri karsilayan tek tek elemanlarin seçimi, daha sonra, bu elemanlarin, rahatlik ve koruma açisindan özel kriterleri karsilayacak sekilde birlestirilmesiyle elde edilmektedir.
Patent TR-199901907-T2 (TR)
Inventor: BERGKVIST MIKAEL
IPC: H02H9/02
Filed: 1997-12-17
Abstract: Elektrik güç anahtarlamasi için bir cihaz olup, en az bir elektrik anahtar düzenlemesi içerir.  Bu anahtar düzenlemesi bir elektrot boslugu içeren en az bir anahtar elemani (10a) içerir. Bu bosluk elektriksel olarak büyük ölçüde yalitkan durum ile elektriksel olarak iletken durum arasinda dönüsebilir. Ayrica, anahtar elemani elektrot boslugunun veya en azindan bir bölümünün elektriksel iletkenlik kazanmasi saglamak veya en azindan baslatmak için yollar (25) içerir. Elektrot bosluguna elektriksel olarak iletkenlik saglamak veya en azindan baslatmak için bu yollar elektrot bosluguna isin enerjisi formunda enerji saglayarak bu isin enerjisi araciligi ile boslugun veya en azindan bir bölümünün plazma olusturmasi için uyarlanir.
Patent TR-199902335-T2 (TR)
Inventor: GRINNELL BRIAN WILLIAM
IPC: A61P9/00
Filed: 1998-03-24
Abstract: The use of activated protein C for the manufacture of a medicament for the treatment of vascular occlusive and thromboembolic disorders at a dose of about 0.01mg/kg/hr to about 0.05mg/kg/hr.
Patent DE-60001153-T2 (DE)
Inventor: GINSBERG MICHAEL
IPC: G06F9/445
Filed: 2000-03-03
Granted: 2003-05-15
Abstract: A method and system are described for updating software modules bundled in a read-only device of a computer. According to the invention, when a software module is to be executed from the read-only device, the operating system identifies any other software modules stored within the read-only device on which the application depends. After identifying all of the dependencies, the operating determines whether a newer version of any of the identified software modules has been installed on the computer. The operating system copies into a read/write device a portion of the software module that references the old software modules. After copying the portion, the operating system modifies all references to point to the new versions of the software module. The invention allows software modules to be primarily executed from the read-only device with only a small updated portion being executed from a read/write device.
Patent DE-60006020-T2 (DE)
Inventor: LEPELLETIER YVES
IPC: C23F13/08
Filed: 2000-02-11
Granted: 2004-06-24
Abstract: Device comprises a column (1) having at its end a insulating element (5) supporting a non-consumable anode (3). Protective sealing sheath (6) is placed between anode (3) and insulating element (5) inside the container to eliminate electrolytic oxidati of the insulating element (5) which is joined to a screen (7) to avoid electrochemical corrosion on the insulating element surfa (5). The screen (7) can be in the form of a cap surrounding and compressing most of the insulating element (5) and has an orific for the non-consumable anode.
Patent DE-60007674-T2 (DE)
Inventor: OSAKABE HIROYUKI
IPC: F28D15/02
Filed: 2000-03-03
Granted: 2004-12-09
Abstract: A boiling and cooling apparatus (1) is provided which has a refrigerant tank (3) for maintaining a liquid refrigerant for boiling when it receives heat from a heating body (2), a radiator (4) which receives refrigerant vapor boiled in the refrigerant tank (3). The radiator (4) cools refrigerant vapor to form the liquid refrigerant by exchanging heat with an external fluid. The radiator (4) includes a first passage (25) for receiving the refrigerant vapor and a second passage (26) for returning condensed liquid to the refrigerant tank (3). The radiator (4) has an upper space which provides communication between the first passage (25) and the second passage (26), whereby the refrigerant vapor is guided to flow preferentially into the first passage (25). <IMAGE>
Patent DE-60008970-T2 (DE)
Inventor: DUGUE JACQUES
IPC: F27B7/36
Filed: 2000-06-20
Granted: 2005-02-10
Abstract: The flame comprises a primary combustion zone for e.g. fuel and oxidant, close to the fuel and oxidant injection points (23, 22). In addition the flame comprises a second combustion zone downstream, where a second fuel (24, 25) (low quality) and oxidant (21) burn. The second fuel is preheated by passage through the primary flame zone.
Patent DE-60014410-T2 (DE)
Inventor: LELOUP JEROME
IPC: B01J35/04
Filed: 2000-12-20
Granted: 2006-03-02
Abstract: Methods and apparatus for treating a gas-liquid feed stream with structured monolithic catalysts of honeycomb configuration wherein the catalysts are configured as a stack of honeycomb sections with offset channels, the resulting channel dislocations between adjacent contacting honeycombs in the stack introducing controlled, limited turbulence and mixing of feed stream portions traversing the channels to significantly increase the catalytic efficiency of the reactor. <IMAGE>
Patent DE-60015356-T2 (DE)
Inventor: GIRARDOT JEAN-MARIE
IPC: A61L27/38
Filed: 2000-08-10
Granted: 2005-10-13
Abstract: Allograft tissue prostheses, as well as tissue valves for replacement of defective heart valves and other tissue-engineered products (TEPs), are effectively sterilized by treatment with a coupling agent known to create amide linkages between amines and carboxylic acids in the presence of a protecting agent. The sterilization treatment preferably employs EDC as a water-soluble coupling agent, plus a water-soluble protecting agent which complexes with potentially reactive amine or carboxyl moieties on the biological tissue, in the optional presence of isopropanol or an equivalent alkanol. One preferred sterilization treatment process uses a buffered aqueous solution where a hydroxymonoamine buffer, such as TRIS plus ethanolamine, provides both the buffering effect and the protecting agents, effectively complexing with potentially reactive carboxyl moieties on the tissue. The treatment is particularly advantageous for sterilizing fresh biological tissue where substantial cross-linking that would alter physical properties of the tissue is undesirable or any tissues or TEPs where a controllable amount of cross-linking is desired.
Patent DE-60025226-T2 (DE)
Inventor: WHITBOURNE J
IPC: A61M25/02
Filed: 2000-08-04
Granted: 2006-08-03
Abstract: A part that can be introduced and/or implanted in the body, in body parts, or in body cavities, made of nonmetallic material or having a nonmetallic surface is designed such that infections associated with the use of parts of this type are reduced or entirely eliminated. This is achieved due to the fact that the entire surface of this part or parts or, depending on the effect, partial areas of this part or parts, that are nevertheless not in geometric contact, is/are furnished with a metallization (6). It is also possible that the material at least in the area of its exterior surface (17) contains metallic particles (18) in powder or granular form made of a metal having an oligodynamic effect, and that the most exterior metallic particles (18) are uncovered at least partially at the surface.
Patent DE-60027014-T2 (DE)
Inventor: FERRELL W
IPC: H01L21/32
Filed: 2000-08-08
Granted: 2007-03-29
Abstract: Method and system for controllable deposit of copper onto an exposed surface of a workpiece, such as a semiconductor surface. A seed thickness of copper is optionally deposited onto the exposed surface, preferably using oxygen-free liquid ammonia to enhance this deposition. The workpiece exposed surface is then immersed in an electroplating solution, including copper and liquid ammonia at a suitable pressure and temperature, and copper is caused to plate onto the exposed surface at a controllable rate. When the copper deposited on the exposed surface reaches a selected total thickness, electroplating is discontinued, the electroplating solution is removed, and the gaseous and liquid ammonia are recovered and recycled for re-use.
Patent DE-60028086-T2 (DE)
Inventor: SUNKARA HARI B
IPC: C08G65/34
Filed: 2000-12-15
Granted: 2006-12-21
Abstract: A process for the manufacture of polytrimethylene ether glycol comprising the steps of: (a) providing (1) 1,3-propanediol reactant selected from the group consisting of 1,3-propanediol and/or oligomers or prepolymers of 1,3-propanediol having a degree of polymerization of 2-9 and mixtures thereof, and (2) a polycondensation catalyst; and (b) polycondensing the 1,3-propanediol reactant to form a polytrimethylene ether glycol at less than one atmosphere pressure, and the product of the process. In addition, polytrimethylene ether glycol has a number average molecular weight greater than 1,500, an APHA color of less than 120, an unsaturation of less than 20 meq/kg, and a content of cyclic ether oligomers of less than 2%.
Patent DE-60028541-T2 (DE)
Inventor: GILBERT MICHEL
IPC: C12N1/21
Filed: 2000-02-01
Granted: 2007-06-06
Abstract: This invention provides prokaryotic glycosyltransferases, including a bifunctional sialyltransferase that has both an ±2,3- and an ±2,8-activity. A ²1,4-GalNAc transferase and a ²1,3-galactosyltransferase are also provided by the invention, as are other glycosyltransferases and enzymes involved in synthesis of lipooligosaccharide (LOS). The glycosyltransferases can be obtained from, for example,  Campylobacter  species, including C.  jejuni.  In additional embodiments, the invention provides nucleic acids that encode the glycosyltransferases, as well as expression vectors and host cells for expressing the glycosyltransferases.
Patent DE-60035046-T2 (DE)
Inventor: AUGUSTIN NUSSBAUM
IPC: G04B19/00
Filed: 2000-09-14
Granted: 2008-01-24
Abstract: The bracelet (6) for a wrist watch has a casing shell to which the straps are attached. The shell (3) has a concave recess to receive a reversible watch insert. The insert has convex faces (16) to allow fitting into the shell with either side facing outwardly. The shell has curved sidewalls to match the watch surface.
Patent DE-60035987-T2 (DE)
Inventor: COOLIDGE THOMAS R
IPC: A61K38/00
Filed: 2000-05-01
Granted: 2008-05-08
Abstract: It has now been discovered that GLP-1 treatment after acute stroke or hemorrhage, preferably intravenous administration, can be an ideal treatment because it provides a means for optimizing insulin secretion, increasing brain anabolism, enhancing insulin effectiveness by suppressing glucagon, and maintaining euglycemia or mild hypoglycemia with no risk of severe hypoglycemia.
Patent DE-60105753-T2 (DE)
Inventor: MERRILL DEBRA ANN
IPC: A23J3/34
Filed: 2001-02-02
Granted: 2006-03-09
Abstract: The invention relates to a method for producing a glutamine-rich gluten-free peptide preparation from gluten protein, comprising the steps of enzymatically hydrolysing wheat gluten using one or more proteases to obtain a hydrolysate; acidifying the hydrolysate to a pH between 4 and 5; and filtering the hydrolysate to obtain the glutamine-rich gluten-free peptide preparation as the filtrate. The protease is preferably a neutral or basic protease and the optimum pH is from 4.5 to 4.7.
Patent DE-60106050-T2 (DE)
Inventor: HEIER JAKOB
IPC: B41M5/00
Filed: 2001-07-16
Granted: 2005-11-17
Abstract: The invention relates to a method for providing in a foil a number of recesses which are arranged relative to each other in a recess pattern extending along a first side of the foil, each recess extending from a first side in the direction of an opposite, second side of the foil, the method comprising at least the following steps: (a) applying a medium pattern onto the unprocessed foil, the medium comprising a medium solvable in solvent, the medium pattern corresponding to the recess pattern to be provided; (b) applying the masking layer onto the foil; (c) bringing the foil, with the masking layer applied thereto, into contact with a solvent, whereby the parts of the masking layer applied substantially on the medium pattern are removed from the foil upon dissolution of the medium pattern; and (d) at least partly exposing the foil with the pattern of openings to a foil etching environment, whereby the recess pattern is created, characterized in that in step (a) the application of a medium pattern is executed with the aid of a printing technique.
Patent DE-60106918-T2 (DE)
Inventor: REITAN HEGE
IPC: B62D1/184
Filed: 2001-05-31
Granted: 2005-12-01
Abstract: A device for allowing adjustment of the angular position of a steering member, like a steering wheel in a vehicle. An upper portion of the device is connected to the steering member. A lower portion is supported in the vehicle. A connection between the upper and lower portions permits pivoting of the upper portion along a curved path with respect to the lower portion, enabling adjustment of the steering member to a plurality of angular positions relative to the lower portion. The center of curvature of the curved path is located between the steering member and the driver in the approximate vicinity of the wrist of the driver.